Ole Søgaard

Professor

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ole Søgaard is a Professor at Aarhus Universitet in Denmark. His research focuses on virology, particularly in the areas of HIV cure trials and SARS-CoV-2 immunity. Recent publications include studies on HIV viral rebound, immune responses to vaccination, and single-cell analysis of immune cells related to antiviral activity. He is actively engaged in exploring immunotherapy as a potential functional cure for HIV-1.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Julie fox

University College London

UNITED KINGDOM

Ole Søgaard

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Factors influencing virologic control during analytical treatment interruptions in HIV cure trials - a pooled analysis of individual level data.

Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 Antibodies.

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2

Single-Cell Analysis Reveals That CD47 mRNA Expression Correlates with Immune Cell Activation, Antiviral Isgs, and Cytotoxicity

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity

Longitudinal evaluation of SARS-CoV-2 T cell immunity over 2 years following vaccination and infection

Development of single-cell transcriptomic atlas of human plasmacytoid dendritic cells from people with HIV-1

Utilizing immunotherapy towards achieving a functional cure for HIV-1.

Nanobody-mediated complement activation to kill HIV-infected cells

Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study.

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial.

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial

CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: author's response

Collaborators (22)

Julie fox

Martin Tolstrup

Jacob Thyrsted

Mads Kjolby

Line Reinert

Ida Monrad Johannsen

Nick Stub Laursen

Thomas Benfield

Jesper Gunst

Javier Martinez-Picado

Rikke Olesen

Nina Breinholt Stærke

Paul Denton

Lars Østergaard

Anna Karina Juhl

Kristine Raaby Jakobsen

Martin R. Jakobsen

Stine Sofie Frank Nielsen

Jacob Bodilsen

Christian Brander

Maria C. Puertas

Renee M. van der Sluis

Make your next move.